Results 91 to 100 of about 36,254 (205)
Treatment application of rivaroxaban in Chinese patients with livedoid vasculopathy
Wenji Chen,1 Lina Fan,1 Yanyan Wang,2 Xiaohu Deng2 1Department of Rheumatology, Hainan Branch of Chinese People’s Liberation Army General Hospital, Sanya, 2Department of Rheumatology, Chinese People’s Liberation Army General Hospital, Beijing,
Fan L, Chen W, Deng XH, Wang Y
core
Rivaroxaban-induced hemorrhage associated with ABCB1 genetic defect
We report a patient who presented a non-ST segment elevation myocardial infarction in the context of severe normocytic hypochromic anemia related to gastrointestinal bleeding, three months after switching anticoagulant from the vitamin K antagonist ...
Kuntheavy Ing Lorenzini +4 more
doaj +1 more source
ZusammenfassungRivaroxaban (Xarelto®), ein neuartiger oraler, direkter Faktor-Xa-Hemmer, ist in klinischer Entwicklung zur Prävention und Behandlung thromboembolischer Erkrankungen. Rivaroxaban hemmt die Clot-assoziierte und die freie Faktor-Xa-Aktivität,
D. Kubitza, F. Misselwitz, E. Perzborn
core +1 more source
Management of Left Atrial Appendage Thrombi and Spontaneous Echo Contrast
ABSTRACT Background To analyze the efficacy and safety of various anticoagulation strategies/regimen used for managing thrombus or spontaneous echo contrast in the left atrial appendage. Methods Thrombus or spontaneous echo contrast in the left atrial appendage was detected via transesophageal echocardiography in 83 patients, most often during a stroke
Timnou Bekouti Jean +10 more
wiley +1 more source
Comparative Bleeding Risk of Brand Vs Generic Rivaroxaban in Elderly Inpatients with Atrial Fibrillation [PDF]
Guoquan Chen,1,* Jiale Chen,1,* Qiang Zhao,2 Yalan Zhu1 1Department of Pharmacy, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, 321000, People’s Republic of China; 2Department of Cardiology, Affiliated Jinhua Hospital,
Chen J, Zhu Y, Zhao Q, Chen G
core
ABSTRACT Background Left atrial appendage occlusion (LAAO) has emerged as a non‐pharmacological alternative to oral anticoagulation (OAC) for stroke prevention in patients with atrial fibrillation (AF). Following the publication of recent CHAMPION‐AF and CLOSURE‐AF trials, an updated synthesis of evidence is warranted to clarify the long‐term ...
Ahmed Nazmy +11 more
wiley +1 more source
Direct oral anticoagulants, such as apixaban and rivaroxaban, are important for the treatment and prophylaxis of venous thromboembolism and to reduce the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
Yukio Otsuka +3 more
doaj +1 more source
ABSTRACT Objectives Post‐endoscopic retrograde cholangiopancreatography (post‐ERCP) bleeding occurs more frequently in dialysis patients than in non‐dialysis patients. This study aimed to identify risk factors for post‐ERCP bleeding following stone removal in patients undergoing dialysis.
Masaki Nishimura +16 more
wiley +1 more source
Probable Rivaroxaban-Induced Full Body Rash: A Case Report.
Introduction: Rivaroxaban is a novel oral anticoagulant with several indications, one of which is for stroke prevention in nonvalvular atrial fibrillation. We present a case of probable rivaroxaban-induced rash.
James, Marian +9 more
core +1 more source
ABSTRACT Ingested toothpicks can perforate the gastrointestinal tract and penetrate adjacent organs. Pancreatic involvement is rare, and its management varies between surgical and endoscopic interventions. We report the successful endoscopic removal of a toothpick that penetrated the gastric wall and extended into the head of the pancreas.
Ken Nakayama +9 more
wiley +1 more source

